How much did Generare raise?

Generare raised $22M at Series A, announced 2 April 2026.

Who founded Generare?

Guillaume Vandenesch is CEO & Co-founder of Generare.

What does Generare do?

Generare operates in HealthTech and is based in France.

FundedStartupsDaily / HealthTech / Generare

Generare raises $22M

Generare announced a Series A round of $22M on 2 April 2026. The company operates in HealthTech and is based in France. It was founded by Guillaume Vandenesch, CEO & Co-founder.

Raised

$22M

Stage

Series A

Industry

HealthTech

Country

France

Founder

Guillaume Vandenesch

CEO & Co-founder, Generare

LinkedIn profile generare.bio

Outreach angles

-Guillaume co-founded Generare in 2023 alongside Dr. Vincent Libis, who brings a decade of synthetic biology research and prior co-founding experience at Abolis Biotechnologies - a team combining commercial and scientific depth.
-He secured a European Research Council (ERC) grant early in the company's life, validating Generare's evolution-based molecular discovery platform before seeking commercial funding.
-The EUR 20M Series A co-led by Alven and Daphni will scale Generare's novel small molecule library tenfold by 2027 to meet growing demand from pharmaceutical and agrochemical companies.